In a remarkable week for venture capital, the spotlight shone brightly on artificial intelligence (AI) and robotics, with several companies securing substantial funding to propel their innovative projects forward. The week of September 13-19, 2025, witnessed a series of high-profile funding rounds, underscoring the growing investor confidence in technologies that promise to reshape industries and enhance human capabilities. Among the standout deals was Figure, a San Jose-based humanoid robot developer, which raised an impressive $1 billion in its Series C financing round, setting a new benchmark in the robotics sector.
Figure’s monumental funding round, led by Parkway Venture Capital, not only highlights the increasing interest in humanoid robotics but also reflects the company’s ambitious vision to create general-purpose robots capable of performing a variety of tasks. With a post-money valuation of $39 billion, Figure is positioning itself at the forefront of the robotics revolution, aiming to integrate humanoid robots into everyday life and various industries. The implications of this funding extend beyond mere financial support; they signal a shift in how society perceives and interacts with robotic technology.
The demand for humanoid robots is driven by their potential applications across multiple sectors, including healthcare, manufacturing, and service industries. As businesses seek to automate routine tasks and improve efficiency, humanoid robots like those developed by Figure could play a crucial role in addressing labor shortages and enhancing productivity. The funding will enable Figure to accelerate its research and development efforts, refine its technology, and expand its production capabilities, ultimately bringing its robots closer to market readiness.
Following closely behind Figure, Groq, a provider of AI compute infrastructure, secured $750 million in funding to bolster its cloud and on-premise AI compute centers. This funding round, led by Disruptive Technology Advisers, values Groq at $6.9 billion. The company specializes in designing chips known as Language Processing Units (LPUs), which are essential for powering advanced AI applications. As the demand for AI-driven solutions continues to surge, Groq’s innovative approach to AI infrastructure positions it as a key player in the rapidly evolving tech landscape.
The funding received by Groq underscores the critical role that robust AI infrastructure plays in enabling organizations to harness the full potential of artificial intelligence. With this capital infusion, Groq aims to scale its operations, enhance its product offerings, and meet the growing demand for AI compute power. The investment reflects a broader trend in the tech industry, where companies are increasingly recognizing the importance of investing in foundational technologies that support AI development.
In the realm of manufacturing technology, Divergent Technologies, based in Torrance, California, closed a $290 million Series E financing round, achieving a valuation of $2.3 billion. Divergent is known for its digital manufacturing platform, which leverages advanced software and automation to streamline production processes. The funding, led by Rochefort Asset Management, will enable Divergent to further develop its platform and expand its market presence.
As industries worldwide grapple with supply chain challenges and the need for greater efficiency, Divergent’s innovative solutions offer a pathway to more agile and responsive manufacturing practices. The company’s focus on digital transformation aligns with the broader trend of Industry 4.0, where technology is integrated into every aspect of manufacturing, from design to production and distribution.
Another notable funding round was secured by Lila Sciences, a Cambridge-based company specializing in AI tools for scientific research. Lila raised $235 million in a Series A funding round, marking a significant milestone for the company. The investment will support the development of AI-driven solutions that enhance research capabilities across various scientific disciplines. By leveraging machine learning and data analytics, Lila aims to accelerate discoveries and improve outcomes in fields such as pharmaceuticals, biotechnology, and environmental science.
The intersection of AI and scientific research is becoming increasingly important as researchers seek to analyze vast amounts of data and derive meaningful insights. Lila’s innovative approach positions it as a leader in this emerging field, and the funding will enable the company to attract top talent, expand its product offerings, and establish strategic partnerships with research institutions and organizations.
In the robotics sector, Dyna Robotics, based in Redwood City, California, raised $120 million in a Series A funding round to advance its development of foundation models for robots. These models aim to enable robots to perform daily tasks with greater autonomy and adaptability, moving closer to the goal of physical artificial general intelligence (AGI). The funding round was co-led by Robostrategy, CRV, and First Round Capital, reflecting strong investor confidence in Dyna’s vision.
Dyna Robotics’ focus on creating adaptable robots has significant implications for various industries, including logistics, healthcare, and home automation. As the demand for intelligent automation solutions grows, Dyna’s innovative approach could position it as a key player in the future of robotics. The funding will allow the company to enhance its research efforts, refine its technology, and bring its products to market more rapidly.
Colossal Biosciences, an Austin-based startup known for its ambitious de-extinction projects, also secured $120 million in funding during this period. The company aims to bring back extinct species, including the woolly mammoth and the dodo, through advanced genetic engineering techniques. The funding will support Colossal’s efforts to build a new avian research facility dedicated to its work on the dodo, showcasing the intersection of biotechnology and conservation.
The concept of de-extinction raises ethical and ecological questions, but it also presents opportunities for advancing scientific knowledge and biodiversity conservation. Colossal’s innovative approach could pave the way for breakthroughs in genetics and conservation biology, and the funding will enable the company to expand its research capabilities and engage with stakeholders in the scientific community.
In the realm of AI software, Invisible Technologies, based in San Francisco, raised $100 million to grow its enterprise AI platform. The company reported $134 million in revenue last year, highlighting its traction in the market. The funding will support the development of new features and enhancements to its platform, which aims to streamline business processes and improve operational efficiency for enterprises.
Invisible Technologies’ focus on AI-driven solutions aligns with the growing demand for automation and efficiency in the corporate world. As businesses seek to optimize their operations and reduce costs, platforms like Invisible’s offer valuable tools for achieving these goals. The funding will enable the company to invest in research and development, expand its customer base, and enhance its competitive position in the market.
Upscale AI, a Palo Alto-based company specializing in AI networking technology, emerged from stealth mode with over $100 million in seed funding. Co-led by Mayfield Fund and Maverick Silicon, this funding will support Upscale’s mission to develop next-generation AI networking solutions. The company’s innovative approach aims to address the challenges of scaling AI applications and improving connectivity in increasingly complex networks.
As AI continues to permeate various sectors, the need for robust networking solutions becomes paramount. Upscale AI’s focus on developing technology that enhances the performance and reliability of AI applications positions it as a key player in the evolving landscape of AI infrastructure. The funding will enable the company to accelerate its product development and establish itself as a leader in the AI networking space.
Ollin Biosciences, a clinical-stage biopharmaceutical company based in Austin, Texas, also secured $100 million in initial funding to develop therapies for vision-threatening diseases. The investment, led by Arch Venture Partners, Mubadala, and Monograph Capital, will support Ollin’s mission to address unmet medical needs in ophthalmology. The company’s focus on innovative therapies aligns with the growing demand for advancements in healthcare and biopharmaceuticals.
The funding landscape for biotech companies remains robust, driven by the increasing need for innovative solutions to address pressing health challenges. Ollin’s commitment to developing therapies for vision-related conditions reflects the broader trend of leveraging cutting-edge science and technology to improve patient outcomes. The funding will enable the company to advance its clinical programs and bring its therapies closer to market.
Lastly, Chestnut Carbon, based in New York, raised $90 million in additional funds for its Series B financing to expand its reforestation and carbon offset projects. The company focuses on generating U.S. forest carbon offsets through conservation initiatives, contributing to climate change mitigation efforts. The funding will support Chestnut Carbon’s mission to restore ecosystems and promote sustainable land management practices.
As the urgency of addressing climate change intensifies, companies like Chestnut Carbon play a vital role in promoting environmental sustainability. The funding will enable the company to scale its operations, enhance its impact, and engage with stakeholders in the environmental and conservation sectors.
Overall, the funding activity during this week highlights the diverse range of innovations attracting significant capital in the venture ecosystem. From humanoid robots to AI infrastructure, de-extinction efforts, and biopharmaceutical advancements, the breadth of investment reflects a growing recognition of the transformative potential of technology across various sectors. As these companies leverage their funding to drive innovation and growth, the implications for industries and society at large are profound, paving the way for a future where technology and human ingenuity converge to address some of the world’s most pressing challenges.